Sign Up to like & get recommendations! 2
Published in 2023 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3610
Abstract: The aim of this systematic review was to analyse whether there is an association between severe hypoglycaemia and the incidence of dementia in patients with type 2 diabetes mellitus. We systematically searched the MEDLINE, Scopus,… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Diabetologia"
DOI: 10.1007/s00125-017-4233-3
Abstract: Aims/hypothesisThe aim of this study was to compare cognitive function in adults with type 1 diabetes who have impaired awareness of hypoglycaemia with those who have normal awareness of hypoglycaemia. A putative association was sought… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Diabetologia"
DOI: 10.1007/s00125-017-4527-5
Abstract: Aims/hypothesisEvidence for the effectiveness of interstitial glucose monitoring in individuals with type 1 diabetes using multiple daily injection (MDI) therapy is limited. In this pre-specified subgroup analysis of the Novel Glucose-Sensing Technology and Hypoglycemia in… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Diabetologia"
DOI: 10.1007/s00125-019-05076-5
Abstract: Aims/hypothesis Approximately 25% of people with type 1 diabetes have suppressed counterregulatory hormonal and symptomatic responses to insulin-induced hypoglycaemia, which renders them at increased risk of severe, disabling hypoglycaemia. This is called impaired awareness of… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Diabetologia"
DOI: 10.1007/s00125-019-05080-9
Abstract: Aims/hypothesis A head-to-head randomised trial was conducted to evaluate hypoglycaemia safety with insulin degludec 200 U/ml (degludec U200) and insulin glargine 300 U/ml (glargine U300) in individuals with type 2 diabetes treated with basal insulin. Methods This… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Diabetologia"
DOI: 10.1007/s00125-020-05369-0
Abstract: The discovery of insulin and its subsequent mass manufacture transformed the lives of people with type 1 and 2 diabetes. Insulin, however, was a drug with a ‘dark side’. It brought with it the risk… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Diabetologia"
DOI: 10.1007/s00125-021-05382-x
Abstract: It is generally accepted that hypoglycaemia can negatively impact the quality of life (QoL) of people living with diabetes. However, the suitability of patient-reported outcome measures (PROMs) used to assess this impact is unclear. The… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Diabetologia"
DOI: 10.1007/s00125-025-06536-x
Abstract: Severe hypoglycaemia events (SHE) remain frequent in people with type 1 diabetes despite advanced diabetes technologies. We examined whether time below range (TBR) 3.9 mmol/l (70 mg/dl; TBR70) or 3.0 mmol/l (54 mg/dl; TBR54) is… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Journal of Pediatrics"
DOI: 10.1007/s00431-019-03554-x
Abstract: Gestational diabetes mellitus (GDM) is an increasing problem worldwide. Postnatal hypoglycaemia and excess foetal growth are known important metabolic complications of neonates born to women with diabetes. This retrospective cohort study aims to determine the… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Current Diabetes Reports"
DOI: 10.1007/s11892-019-1135-4
Abstract: Purpose of ReviewTo highlight the central role of hypoglycaemia in the causation of cognitive frailty and explore ways of recognition and prevention of hypoglycaemia.Recent FindingsCognitive frailty is an emerging new concept defined as the concomitant… read more here.